PAVmed Inc – NASDAQ:PAVMZ
PAVmed stock price today
PAVmed stock price monthly change
PAVmed stock price quarterly change
PAVmed stock price yearly change
PAVmed key metrics
Market Cap | 4.62M |
Enterprise value | 39.45M |
P/E | -0.09 |
EV/Sales | 104.66 |
EV/EBITDA | -0.39 |
Price/Sales | 23.65 |
Price/Book | -0.92 |
PEG ratio | N/A |
EPS | -7.93 |
Revenue | 3.01M |
EBITDA | -60.55M |
Income | -61.53M |
Revenue Q/Q | 126.45% |
Revenue Y/Y | 375.70% |
Profit margin | -23677.45% |
Oper. margin | -24118.57% |
Gross margin | -858.62% |
EBIT margin | -24118.57% |
EBITDA margin | -2007.63% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePAVmed stock price history
PAVmed stock forecast
PAVmed financial statements
| Jun 2023 | 166K | -14.53M | -8757.23% |
|---|---|---|---|
| Sep 2023 | 791K | -17.74M | -2243.74% |
| Dec 2023 | 1.04M | -14.03M | -1338.04% |
| Mar 2024 | 1.01M | -15.21M | -1506.14% |
| Jun 2023 | 53683000 | 54.51M | 101.55% |
|---|---|---|---|
| Sep 2023 | 42020000 | 57.84M | 137.67% |
| Dec 2023 | 33119000 | 57.13M | 172.52% |
| Mar 2024 | 37254000 | 57.82M | 155.23% |
| Jun 2023 | -12.78M | -15K | 684K |
|---|---|---|---|
| Sep 2023 | -11.08M | -18K | 352K |
| Dec 2023 | -11.87M | -183K | 5.28M |
| Mar 2024 | -13.10M | -42K | 19.04M |
PAVmed alternative data
| Jan 2024 | 124 |
|---|---|
| Feb 2024 | 124 |
| Mar 2024 | 124 |
| Apr 2024 | 124 |
| May 2024 | 107 |
| Jun 2024 | 107 |
| Jul 2024 | 107 |
PAVmed other data
| Period | Buy | Sel |
|---|---|---|
| Dec 2022 | 250000 | 0 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Purchase | GLENNON MICHAEL J director | Common Stock | 100,000 | $0.62 | $62,300 | ||
Purchase | GLENNON MICHAEL J director | Common Stock | 88,000 | $0.64 | $56,056 | ||
Purchase | GLENNON MICHAEL J director | Common stock | 62,000 | $0.69 | $42,594 | ||
Purchase | AKLOG LISHAN director, 10 perc.. | Common Stock | 7,500 | $4.31 | $32,325 | ||
Purchase | AKLOG LISHAN director, 10 perc.. | Common Stock | 7,500 | $4.31 | $32,325 | ||
Sale | SIROVICH MATTHEW 10 percent owner | Common Stock | 33,203 | $1.96 | $65,045 | ||
Sale | SIROVICH MATTHEW 10 percent owner | Common Stock | 53,036 | N/A | N/A | ||
Sale | SIROVICH MATTHEW 10 percent owner | Common Stock | 75,211 | N/A | N/A | ||
Sale | SIROVICH MATTHEW 10 percent owner | Common Stock | 24,789 | N/A | N/A | ||
Sale | SIROVICH MATTHEW 10 percent owner | Common Stock | 131,082 | N/A | N/A |
-
What's the price of PAVmed stock today?
One share of PAVmed stock can currently be purchased for approximately $0.
-
When is PAVmed's next earnings date?
Unfortunately, PAVmed's (PAVMZ) next earnings date is currently unknown.
-
Does PAVmed pay dividends?
No, PAVmed does not pay dividends.
-
How much money does PAVmed make?
PAVmed has a market capitalization of 4.62M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 550.4% to 2.45M US dollars.
-
What is PAVmed's stock symbol?
PAVmed Inc is traded on the NASDAQ under the ticker symbol "PAVMZ".
-
What is PAVmed's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of PAVmed?
Shares of PAVmed can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does PAVmed have?
As Jul 2024, PAVmed employs 107 workers, which is 14% less then previous quarter.
-
When PAVmed went public?
PAVmed Inc is publicly traded company for more then 7 years since IPO on 10 Apr 2018.
-
What is PAVmed's official website?
The official website for PAVmed is pavmed.com.
-
How can i contact PAVmed?
PAVmed can be reached via phone at +212 9494319.
PAVmed company profile:
PAVmed Inc
pavmed.comNASDAQ
107
Medical - Devices
Healthcare
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
New York, 10017
CIK: 0001624326
ISIN: US70387R1225
CUSIP: 70387R122
